company insight

HOF Sonderanlagenbau
Quality is key...

Hot Freeze Drying Systems -
The specialist for individual solutions.

01 / What makes HOF unique?

Founded in 1988, HOF has developed to one of the top suppliers for pharmaceutical freeze-drying equipment, meaning freeze dryers from the laboratory scale up to production maximal production sizes, as well as specific loading and unloading devices. Furthermore, units for rapid freezing and thawing of medical and biotech products are part of our portfolio.

Nevertheless, HOF has no standard product catalogue: every system or installation is individually designed for the customer’s needs – performance parameters, space availability and room limitations as well as specified components and materials are incorporated.

“Just in time quality for our demanding customers is our valid philosophy for every single project”

02 / The name HOF stands for…

…advise, innovation, technology, manufacture, quality and expertise. These six arguments are the fundamental basis for every project. All departments and groups involved in a customized project adjust their actions towards these criteria, always focusing on the company’s philosophy and therefore to meet all expectations towards quality, functionality and timing.


Beginning with the first Draft-Layout and the review of the ‘user requirement specification’, all parties involved work hand in hand to maximize the efficiency in the workflow and to present the best results possible. This claim is met throughout the complete runtime of a project until the final acceptance tests at the customer’s site.

all parties involved work hand in hand to maximize the efficiency in the workflow and to present the best results possible

03 / What are the strengths of HOF?

…advise, innovation, technology, manufacture, quality and expertise. These six arguments are the fundamental basis for every project. All departments and groups involved in a customized project adjust their actions towards these criteria, always focusing on the company’s philosophy and therefore to meet all expectations towards quality, functionality and timing.


Beginning with the first Draft-Layout and the review of the ‘user requirement specification’, all parties involved work hand in hand to maximize the efficiency in the workflow and to present the best results possible. This claim is met throughout the complete runtime of a project until the final acceptance tests at the customer’s site.

04 / What do you do in order to be innovative?

For more than 25 years, HOF Sonderanlagenbau GmbH has been developing for-ward-looking technologies, nationally and internationally. An important requirement for all company departments is to develop and plan the future today. HOF employees focus on the technological innovations with the objective to meet new customers’ specific requirements.

The company’s aim for the future is to remain an innovative pioneer in research and development of freeze-drying systems. innovative charging systems, flexible shelf adjustment, use of liquid nitrogen and natural refrigerants, control integration of advanced measuring systems such as NIR and mass spectrometers, HOF SynchroFreeze and vacuum insulation: these are some examples for the company‘s innovative potential and willingness to take on new approaches.

HOF SynchroFreeze is a future oriented technology. This procedure allows a homogeneous freezing thanks to a synchronized nucleation during the freezing process – with a simultaneous reduction of the drying time.

05 / What is the benefit of the innovation HOF SynchroFreeze?

HOF SynchroFreeze is a future oriented technology. This procedure allows a homogeneous freezing thanks to a synchronized nucleation during the freezing process – with a simultaneous reduction of the drying time.

This innovation of HOF, registered for patent approval, provides the customer with further tools to quality improvement of the pharmaceutical product and to more efficiency. 


HOF SynchroFreeze distinguishes itself through a high process reliability and the possibility for retrofitting of existing freeze-drying systems.

Brief Overview of HOF SynchroFreeze:
•  Synchronization of freezing process in individual vials and product containers
•  Increase of the product homogeneity
•  Conditioning of product structure
•  Reduction of drying times

Share this article

Go to article: Home | The Dawn of Big DataGo to article: EditorialGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: ContentsGo to article: Daiichi JitsugyoGo to article: How will Amazon's acquisition of online pharmacy business PillPack disrupt the pharmaceutical industry? Go to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Fentanyl: where did it all go wrong?Go to article: NSFGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: Turning up the heat on nano researchGo to article: TSS Company InsightGo to article: TSS ABGo to article: MedelpharmGo to article: Cracking the mystery of Alzheimer's diseaseGo to article: Röchling Medical NeuhausGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Where are the world's pharma manufacturing hotspots?Go to article: Gerteis Company InsightGo to article: GerteisGo to article: ZenatekGo to article: How India’s use of unapproved antibiotics could undermine global healthGo to article: Novo Nordisk PharmatechGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: CRISPR: a seismic shift in gene editingGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Is the UK’s drug evaluation system in need of an overhaul?Go to article: Nelson Labs Company InsightGo to article: Nelson LabsGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Opening up the Chinese drug marketGo to article: Finnair Cargo | Company InsightGo to article: Finnair CargoGo to article: Immunising against opioids – could a vaccine solve the crisis? Go to article: Molnar Company InsightGo to article: MolnarGo to article: PharmasolGo to article: The next generation of antimalarials Go to article: Oncology Therapeutic Development Company InsightGo to article: Oncology Therapeutic DevelopmentGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: G.F.Go to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: Amazon and PillPack: an unstoppable pharmacy force?Go to article: BEAGo to article: Buchi Labortechnik AG Company InsightGo to article: Buchi Labortechnik AGGo to article: Is the microbiome as important for precision medicine as genetics?Go to article: Medical HempGo to article: Senn ChemicalsGo to article: Senn ChemicalsGo to article: Niconex Medical LtdGo to article: HPV vaccines: a decade of progressGo to article: Med-Script AssociatesGo to article: B&W Tek | Company InsightGo to article: B&W TekGo to article: EventsGo to article: CG ChemikalienGo to article: AlpexGo to article: Next issueGo to article: Pall Biotech Company InsightGo to article: CrewpharmGo to article: EndocaGo to article: Diversey